Works matching IS 20445385 AND DT 2022 AND VI 12 AND IP 11

Results: 16

Bortezomib, Bendamustine and Dexamethasone vs Thalidomide, Bendamustine and Dexamethasone in Myeloma patients presenting with renal failure (OPTIMAL): a randomised, multi-centre phase II trial.

Published in:

Blood Cancer Journal, 2022, v. 12, n. 11, p. 1, doi. 10.1038/s41408-022-00758-7

By:

Ramasamy, Karthik;
Iqbal, Gulnaz;
Brouwer, Richard;
Stalker, Victoria;
Akhtar, Salma;
Varghese, Sherin;
Lindsay, Jindriska;
Schey, Stephen;
Drayson, Mark;
Dunn, Janet

Publication type:

Article

Chronic lymphocytic leukemia treatment algorithm 2022.

Published in:

Blood Cancer Journal, 2022, v. 12, n. 11, p. 1, doi. 10.1038/s41408-022-00756-9

By:

Hampel, Paul J.;
Parikh, Sameer A.

Publication type:

Article

Validation of the revised diagnostic criteria for primary plasma cell leukemia by the Korean Multiple Myeloma Working Party.

Published in:

Blood Cancer Journal, 2022, v. 12, n. 11, p. 1, doi. 10.1038/s41408-022-00755-w

By:

Jung, Sung-Hoon;
Kim, Kihyun;
Yoon, Sang Eun;
Moon, Joon Ho;
Kim, Dajung;
Kim, Hyo Jung;
Kim, Min Kyoung;
Kim, Kyoung Ha;
Lee, Hyun Jung;
Lee, Ji Hyun;
Kim, Sung-Hyun;
Yoo, Kawi Han;
Lee, Jae Hoon;
Lee, Je-Jung

Publication type:

Article

The risk of coronavirus disease 2019 (COVID-19) among individuals with monoclonal B cell lymphocytosis.

Published in:

Blood Cancer Journal, 2022, v. 12, n. 11, p. 1, doi. 10.1038/s41408-022-00754-x

By:

Parikh, Sameer A.;
Achenbach, Sara J.;
Rabe, Kari G.;
Norman, Aaron D.;
Boddicker, Nicholas J.;
Olson, Janet E.;
Call, Timothy G.;
Cerhan, James R.;
Vachon, Celine M.;
Kay, Neil E.;
Braggio, Esteban;
Hanson, Curtis A.;
Slager, Susan L.;
Shanafelt, Tait D.

Publication type:

Article

An effective and chemotherapy-free strategy of all-trans retinoic acid and arsenic trioxide for acute promyelocytic leukemia in all risk groups (APL15 trial).

Published in:

Blood Cancer Journal, 2022, v. 12, n. 11, p. 1, doi. 10.1038/s41408-022-00753-y

By:

Wang, Huai-Yu;
Gong, Sha;
Li, Guo-Hui;
Yao, Ya-Zhou;
Zheng, Yin-Suo;
Lu, Xiao-Hong;
Wei, Su-Hua;
Qin, Wei-Wei;
Liu, Hai-Bo;
Wang, Meng-Chang;
Xi, Jie-Ying;
Chen, Li-Mei;
Zhang, Mei;
Zhang, Xin-Xin;
Zhang, Hui-Yun;
Zhang, Cheng-Sheng;
Wald, David N.;
Zhu, Hong-Hu;
Liu, Li;
He, Peng-Cheng

Publication type:

Article

Second symptomatic COVID-19 infections in patients with an underlying monoclonal gammopathy.

Published in:

Blood Cancer Journal, 2022, v. 12, n. 11, p. 1, doi. 10.1038/s41408-022-00752-z

By:

Zanwar, Saurabh;
Ho, Matthew;
Buadi, Francis K.;
Ailawadhi, Sikander;
Larsen, Jeremy;
Bergsagel, Leif;
Binder, Moritz;
Chanan-Khan, Asher;
Dingli, David;
Dispenzieri, Angela;
Fonseca, Rafael;
Gertz, Morie A.;
Gonsalves, Wilson;
Go, Ronald S.;
Hayman, Suzanne;
Kapoor, Prashant;
Kourelis, Taxiarchis;
Lacy, Martha Q.;
Leung, Nelson;
Lin, Yi

Publication type:

Article

In response to: Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: results of the iStopMM study.

Published in:

Blood Cancer Journal, 2022, v. 12, n. 11, p. 1, doi. 10.1038/s41408-022-00751-0

By:

Minnema, Monique C.;
Jacobs, Joannes F. M.

Publication type:

Article

Characteristics of measurable residual disease assessment in myeloma: a review of clinical trials from 2015–2020.

Published in:

Blood Cancer Journal, 2022, v. 12, n. 11, p. 1, doi. 10.1038/s41408-022-00750-1

By:

Van Oekelen, Oliver;
Birrer, Nicole;
Wesson, William;
Galate, Vincent L.;
Cliff, Edward R. Scheffer;
Goodman, Aaron M.;
Abdallah, Al-Ola;
Chakraborty, Rajshekhar;
Prasad, Vinay;
Mohyuddin, Ghulam Rehman

Publication type:

Article

Breakthrough infections in MPN-COVID vaccinated patients.

Published in:

Blood Cancer Journal, 2022, v. 12, n. 11, p. 1, doi. 10.1038/s41408-022-00749-8

By:

Barbui, Tiziano;
Carobbio, Alessandra;
Ghirardi, Arianna;
Iurlo, Alessandra;
De Stefano, Valerio;
Sobas, Marta Anna;
Rumi, Elisa;
Elli, Elena Maria;
Lunghi, Francesca;
Gasior Kabat, Mercedes;
Cuevas, Beatriz;
Guglielmelli, Paola;
Bonifacio, Massimiliano;
Marchetti, Monia;
Alvarez-Larran, Alberto;
Fox, Laura;
Bellini, Marta;
Daffini, Rosa;
Benevolo, Giulia;
Carreno-Tarragona, Gonzalo

Publication type:

Article

Evaluating complete remission with partial hematologic recovery (CRh) as a response criterion in myelodysplastic syndromes (MDS).

Published in:

Blood Cancer Journal, 2022, v. 12, n. 11, p. 1, doi. 10.1038/s41408-022-00748-9

By:

Brunner, Andrew M.;
Gavralidis, Alexander;
Ali, Najla Al;
Hunter, Anthony;
Komrokji, Rami;
Zeidan, Amer;
Sallman, David A.

Publication type:

Article

The PIP4K2 inhibitor THZ-P1-2 exhibits antileukemia activity by disruption of mitochondrial homeostasis and autophagy.

Published in:

Blood Cancer Journal, 2022, v. 12, n. 11, p. 1, doi. 10.1038/s41408-022-00747-w

By:

Lima, Keli;
Pereira-Martins, Diego Antonio;
de Miranda, Lívia Bassani Lins;
Coelho-Silva, Juan Luiz;
Leandro, Giovana da Silva;
Weinhäuser, Isabel;
Cavaglieri, Rita de Cássia;
Leal, Aline de Medeiros;
da Silva, Wellington Fernandes;
Lange, Ana Paula Alencar de Lima;
Velloso, Elvira Deolinda Rodrigues Pereira;
Griessinger, Emmanuel;
Hilberink, Jacobien R.;
Ammatuna, Emanuele;
Huls, Gerwin;
Schuringa, Jan Jacob;
Rego, Eduardo Magalhães;
Machado-Neto, João Agostinho

Publication type:

Article

Pure (acute) erythroid leukemia: morphology, immunophenotype, cytogenetics, mutations, treatment details, and survival data among 41 Mayo Clinic cases.

Published in:

Blood Cancer Journal, 2022, v. 12, n. 11, p. 1, doi. 10.1038/s41408-022-00746-x

By:

Reichard, Kaaren K.;
Tefferi, Ayalew;
Abdelmagid, Maymona;
Orazi, Attilio;
Alexandres, Christina;
Haack, Joanna;
Greipp, Patricia T.

Publication type:

Article

GATA-3 is a proto-oncogene in T-cell lymphoproliferative neoplasms.

Published in:

Blood Cancer Journal, 2022, v. 12, n. 11, p. 1, doi. 10.1038/s41408-022-00745-y

By:

Geng, Xiangrong;
Wang, Chenguang;
Gao, Xin;
Chowdhury, Pinki;
Weiss, Jonathan;
Villegas, José A.;
Saed, Badeia;
Perera, Thilini;
Hu, Ying;
Reneau, John;
Sverdlov, Maria;
Wolfe, Ashley;
Brown, Noah;
Harms, Paul;
Bailey, Nathanael G.;
Inamdar, Kedar;
Hristov, Alexandra C.;
Tejasvi, Trilokraj;
Montes, Jaime;
Barrionuevo, Carlos

Publication type:

Article

Assessing the role of venetoclax in combination with hypomethylating agents in higher risk myelodysplastic syndrome.

Published in:

Blood Cancer Journal, 2022, v. 12, n. 11, p. 1, doi. 10.1038/s41408-022-00744-z

By:

Komrokji, Rami S.;
Singh, Avani M.;
Ali, Najla Al;
Chan, Onyee;
Padron, Eric;
Sweet, Kendra;
Kuykendall, Andrew;
Lancet, Jeffrey E.;
Sallman, David A.

Publication type:

Article

Increased risk of thrombosis in JAK2 V617F-positive patients with primary myelofibrosis and interaction of the mutation with the IPSS score.

Published in:

Blood Cancer Journal, 2022, v. 12, n. 11, p. 1, doi. 10.1038/s41408-022-00743-0

By:

Barbui, Tiziano;
Ghirardi, Arianna;
Carobbio, Alessandra;
Masciulli, Arianna;
Carioli, Greta;
Rambaldi, Alessandro;
Finazzi, Maria Chiara;
Bellini, Marta;
Rumi, Elisa;
Vanni, Daniele;
Borsani, Oscar;
Passamonti, Francesco;
Mora, Barbara;
Brociner, Marco;
Guglielmelli, Paola;
Paoli, Chiara;
Alvarez-Larran, Alberto;
Triguero, Ana;
Garrote, Marta;
Pettersson, Helna

Publication type:

Article

Survival trends in hematological malignancies in the Nordic countries through 50 years.

Published in:

Blood Cancer Journal, 2022, v. 12, n. 11, p. 1, doi. 10.1038/s41408-022-00728-z

By:

Hemminki, Kari;
Hemminki, Janne;
Försti, Asta;
Sud, Amit

Publication type:

Article